SCHEMBL8208717

SCHEMBL8208717

CC(=O)O[C@H]([C@H](OC(C)=O)[C@H](C=O)OC(C)=O)[C@@H](CO)OC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.46
▸ TSHR P16473 1/20 0.31
▸ TRPV1 Q8NER1 1/20 0.31
▸ ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10509129 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15
SCHEMBL10507358 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15
SCHEMBL17748350 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15
SCHEMBL1534006 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15
SCHEMBL10733105 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15
SCHEMBL10734940 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15
SCHEMBL10509917 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15
SCHEMBL10508529 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15
SCHEMBL3630267 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15
SCHEMBL10511032 1.00 TDP1 (0.46) TDP1TSHRTRPV1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115708883-A Macrophage nanoparticle compound and preparation method and application thereof 珠海中科先进技术研究院有限公司 2023-02-24 — — CN claimed
US-10640526-B2 Method of preparation of 6-azido-2,4-diacetamido-2,4,6-trideoxy-D-mannose CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2020-05-05 — — US claimed
EP-3377508-A1 METHOD OF PREPARATION OF 6-AZIDO-2,4-DIACETAMIDO-2,4,6-TRIDEOXY-D-MANNOSE Centre National De La Recherche Scientifique (FR) 2018-09-26 — — EP claimed
EP-3170832-A1 METHOD OF PREPARATION OF 6-AZIDO-2,4-DIACETAMIDO-2,4,6-TRIDEOXY-D-MANNOSE Centre National De La Recherche Scientifique (FR) 2017-05-24 — — EP claimed
US-12576155-B2 Senolytic and antiinflammatory prodrugs and methods of use thereof PEKING UNIVERSITY (CN) 2026-03-17 — — US disclosed
WO-2024036961-A1 PRODRUG FOR ANTI-AGING RELATED DISEASES AND USE METHOD THEREFOR 北京三秀生物医药科技有限公司 2024-02-22 — — WO disclosed
CN-114341148-B Anti-aging and anti-inflammatory prodrugs and methods of use thereof 北京大学 2024-01-09 — — CN disclosed
CN-115708883-A Macrophage nanoparticle compound and preparation method and application thereof 珠海中科先进技术研究院有限公司 2023-02-24 — — CN disclosed
US-20220362387-A1 SENOLYTIC AND ANTIINFLAMMATORY PRODRUGS AND METHODS OF USE THEREOF PEKING UNIVERSITY (CN) 2022-11-17 — — US disclosed
CN-114341148-A Anti-aging and anti-inflammatory prodrugs and methods of use thereof 北京大学 2022-04-12 — — CN disclosed
WO-2021057061-A1 SENOLYTIC AND ANTIINFLAMMATORY PRODRUGS AND METHODS OF USE THEREOF PEKING UNIVERSITY (CN) 2021-04-01 — — WO disclosed
WO-2021056270-A1 SENOLYTIC PRODRUGS AND METHODS OF USE THEREOF PEKING UNIVERSITY (CN) 2021-04-01 — — WO disclosed
US-5530123-A ANTIVIRAL AND CHEMOTHERAPEUTICAL AGENT FOR CANCER BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1996-06-25 — — US disclosed
US-5457195-A Sapphyrin derivatives and conjugates BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-10-10 — — US disclosed
WO-1994009003-A1 SAPPHYRIN DERIVATIVES, CONJUGATES AND POLYMERS THEREOF AND EXPANDED PORPHYRIN CHROMATOGRAPHIC SUPPORTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1994-04-28 — — WO disclosed
EP-0173462-B1 ELLIPTICINE DERIVATIVE AND PRODUCTION PROCESS THEREOF SUNTORY LIMITED (JP) 1989-10-25 — — EP disclosed
US-4698423-A ANTITUMOR AGENTS SUNTORY LIMITED (JP) 1987-10-06 — — US disclosed
EP-0173462-A2 Ellipticine derivative and production process thereof SUNTORY LIMITED (JP) 1986-03-05 — — EP disclosed
US-4563445-A DETECTION OF GASTROINTESTINAL CHOAY S.A. (FR) 1986-01-07 — — US disclosed
EP-0069678-A2 3-Fucosyl-N-acetyl-lactosamine derivatives, their preparation and their biological applications CHOAY S.A. (FR) 1983-01-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12576155-B2 Senolytic and antiinflammatory prodrugs and methods of use thereof GLA, SENP6, GLB1 TDP1 271/4885TSHR 1161/4885TRPV1 4548/4885
US-20220362387-A1 SENOLYTIC AND ANTIINFLAMMATORY PRODRUGS AND METHODS OF USE THEREOF GLA, SENP6, GLB1 TDP1 468/4885TSHR 2848/4885TRPV1 4102/4885
US-10640526-B2 Method of preparation of 6-azido-2,4-diacetamido-2,4,6-trideoxy-D-mannose ST6GAL1, B4GALT1, GALNT6 TDP1 2029/4885TSHR 191/4885TRPV1 4805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback